Startseite › Eierstockkrebs › Pennsylvania › Philadelphia
Klinische Studien zu Eierstockkrebs in Philadelphia, PA
44 Studien zu Eierstockkrebs suchen Teilnehmer an Standorten in und um Philadelphia (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Teilnehmer gesuchtPhase 2/3
- Thomas Jefferson University Hospital, Philadelphia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- und 4 weitere
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Teilnehmer gesucht
- University of Pennsylvania, Philadelphia
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Teilnehmer gesuchtPhase 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Teilnehmer gesuchtPhase 2
- Site 0232 - University of Pennsylvania, Philadelphia
- Site 0178 - Thomas Jefferson University, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
DESTINY-PANTUMOUR04
Teilnehmer gesuchtBeobachtungsstudie
- Research Site, Philadelphia
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Teilnehmer gesuchtPhase 1/2
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Teilnehmer gesuchtPhase 3
- University of Pennsylvania Hospital, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi entfernt
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Teilnehmer gesuchtPhase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Teilnehmer gesuchtPhase 2
- Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Teilnehmer gesucht
- Fox Chase Cancer Center - Philadelphia, Philadelphia
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Teilnehmer gesuchtPhase 1/2
- University of Pennsylvania, Philadelphia
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Teilnehmer gesuchtPhase 3
- Hospital of the University of Pennsylvania ( Site 0071), Philadelphia
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Teilnehmer gesuchtPhase 3
- Lankenau Medical Center, Wynnewood · 7 mi entfernt
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Teilnehmer gesuchtBeobachtungsstudie
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Teilnehmer gesuchtPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Teilnehmer gesuchtPhase 1
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Teilnehmer gesuchtPhase 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
Teilnehmer gesuchtBeobachtungsstudie
- ACPMP, Springfield · 8 mi entfernt
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Teilnehmer gesuchtPhase 3
- Site 0109, Philadelphia
- Site 0113, Philadelphia
- Site 0114, Willow Grove · 13 mi entfernt
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Teilnehmer gesucht
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · 7 mi entfernt
- und 5 weitere
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Teilnehmer gesuchtPhase 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- und 5 weitere
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Teilnehmer gesuchtPhase 2/3
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Teilnehmer gesuchtPhase 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Investigative Site #109, Philadelphia
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Teilnehmer gesuchtPhase 2
- University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Teilnehmer gesuchtPhase 1
- University of Pennsylvania, Philadelphia
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
Teilnehmer gesuchtPhase 1
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Teilnehmer gesuchtPhase 3
- Lankenau Medical Center/Mainline Medical Center, Wynnewood · 7 mi entfernt
- Jefferson Abington Hospital, Abington · 12 mi entfernt
- Asplundh Cancer Pavilion, Willow Grove · 13 mi entfernt
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Teilnehmer gesucht
- Hospital of the University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Teilnehmer gesuchtPhase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Teilnehmer gesuchtPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Healthy Volunteers Study
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Teilnehmer gesuchtPhase 2
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Philadelphia
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Teilnehmer gesuchtPhase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Teilnehmer gesuchtBeobachtungsstudie
- Gynecologic Oncology Group, Philadelphia
Eierstockkrebs-Studien in anderen Städten
- Houston, TX89 Studien
- New York City, NY69 Studien
- Boston, MA61 Studien
- Los Angeles, CA50 Studien
- Nashville, TN49 Studien
- Arlington, VA46 Studien
- Columbus, OH39 Studien
- St. Louis, MO38 Studien
- Chicago, IL36 Studien
- San Antonio, TX31 Studien
- Cleveland, OH30 Studien
- Pittsburgh, PA30 Studien
Weitere Studien in Philadelphia
- Krebs (alle Arten)59 Studien
- Brustkrebs56 Studien
- Nichtkleinzelliges Lungenkarzinom51 Studien
- Metastasierender Krebs46 Studien
- Prostatakrebs44 Studien
- Kolorektales Karzinom44 Studien
- Lungenkrebs36 Studien
- Akute myeloische Leukämie34 Studien
- Herzinsuffizienz31 Studien
- Endometriumkarzinom28 Studien
- Depression26 Studien
- Bauchspeicheldrüsenkrebs26 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.